I am a part-time investor and full-time psychologist who serves as director of my psychology clinic specializing in adult relationship issues. I like to follow in as much detailed depth as possible one speculative stock which I believe has the most likely tremendous upside potential. Right now that stock is NKTR. Huge strides are being made in immuno-oncology, and NKTR appears uniquely positioned to make the most percentage profit from furthering the therapeutic advances. In addition, NKTR-181 is an another timely potentially blockbuster medication as a nonaddictive opiate pending FDA approval. NKTR-358 may have great potential as a first-in-class medication for autoimmune disorders. I have taught statistics and research methods, and I can read the medical literature with some assistance from other medical resources. I consider NKTR to be a once-in-a-lifetime speculative investment opportunity for me.